Uredba O Nacionalnom Programu Prevencije, Lečenja I Kontrole Kardiovaskularnih Bolesti Do 2020. Godine

Objectives

The National Programme for the prevention, treatment and control of cardiovascular diseases in the Republic of Serbia through 2020 seeks to reduce cardiovascular morbidity and mortality, improve quality of life, reduce health inequalities, and strengthen the health system’s capacity to address the cardiovascular disease burden.[1][2]It adopts health promotion and prevention as central principles, combining action on behavioural, environmental, social and economic determinants of health with improved diagnosis, treatment, rehabilitation and research.[1][2]

• Reduce major cardiovascular risk factors, including tobacco use, hypertension, dyslipidaemia, unhealthy diet, obesity, physical inactivity and diabetes.[3][4][5][6]
• Improve early recognition, screening, diagnosis and treatment to reduce mortality, disability and complications and improve the quality of life of people with cardiovascular disease.[2][7]
• Promote multisectoral action, healthier environments, public knowledge and individual responsibility for health while reducing inequalities.[8][9]
• Achieve specific hypertension targets by reducing the number of people with arterial hypertension by 5%, increasing newly detected cases by 10% through better diagnosis, and reducing complications by 10%.[3]
• Reduce the number of people with dyslipidaemias by 2% annually and establish a register by 2015 for patients with the most severe genetically determined hyperlipoproteinaemias.[4][5]
• Prevent complex congenital heart defects, improve acute coronary syndrome and interventional cardiology care, strengthen arrhythmia and pacemaker services, and eliminate waiting lists for cardiac surgery.[10][11][12][13]
• Support rehabilitation, prevent recurrent cardiovascular events, restore functional capacity after acute illness, and expand prevention-oriented clinical research.[14][15][16]

Implementation

The Programme applies an integrated delivery model spanning population prevention, primary healthcare, specialist and tertiary services, emergency care, rehabilitation, public health surveillance and cross-sector collaboration.[1][8][15]Implementation is grounded in legislation governing healthcare, health insurance, medicines and medical devices, the health-facility network, preventive care and health-service provision.[17]

• Deliver risk-factor prevention through selected doctors in primary healthcare, with one coordinating doctor appointed in each health centre, and use routine examinations and targeted screening to identify obesity, hypertension, dyslipidaemia and type 2 diabetes.[18][7]
• Screen children aged three to 18 every two years through blood-pressure measurement, screen adults in primary healthcare every two years, organise public measurement campaigns, and enrol high-risk people in preventive programmes.[18]
• Promote healthier diets, lower salt and alcohol consumption, weight reduction, physical activity, smoking cessation and stress control, including food labelling for sodium and potassium content.[18]
• Implement tobacco-control measures through cessation programmes, higher tobacco prices, stronger health warnings, reduced smoking among women, agricultural diversification and restrictions on new tobacco-processing facilities.[4]
• Develop guidance and capacity for hypertension and dyslipidaemia management, train educators and health professionals, identify high-risk groups, and ensure pharmacological and non-pharmacological care.[3][18][5]
• Strengthen environmental health action by mapping urban noise in Belgrade, Novi Sad and Niš by 2012, extending mapping to settlements with more than 100,000 inhabitants by 2015, and eliminating critical acoustic zones above 65 decibels A-weighted by 2020.[3]
• Improve pre-hospital and acute care by training primary-care and emergency staff, standardising field equipment, using telecommunications between emergency teams and hospitals, strengthening referral links, and educating the public about timely presentation.[7][19][11]
• Expand specialist capacity through tertiary congenital-heart services, coronary and intensive-care units, catheterisation laboratories, vascular and cardiac surgery, pacemaker services, rehabilitation facilities and workforce education.[10][11][12][20][14][15]
• Coordinate delivery through the Ministry of Health, Republic Health Insurance Fund, Institute of Public Health of Serbia, territorial public health institutes, local government units, health centres, hospitals, medical faculties, professional associations, the Statistical Office of the Republic of Serbia, individuals and the wider community.[15][21]
• Maintain information systems and registers covering population cardiovascular disease, hypertension prevention, severe familial dyslipidaemia, congenital heart defects, acute coronary syndrome, interventional cardiology, arrhythmias, pacemaker services, cardiac surgery and rehabilitation.[9][5][10][11][12][14][15]
• Monitor implementation through prescribed health-statistical data, Programme indicators, direct field inspection and six-monthly reports from health centres, primary-care institutions, cardiovascular clinics, hospital departments and territorial public health institutes to the Institute of Public Health of Serbia.[21]
• Submit a consolidated monitoring report from the Institute of Public Health of Serbia to the Ministry of Health, while supporting international cardiovascular and stem-cell research involving Serbian institutions and researchers.[21]
• Finance implementation through the Republic of Serbia budget under the Ministry of Health, subject to budgetary capacity, and through resources planned in the financial plan of the Republic Health Insurance Fund; no numeric budget or costed allocations are specified.[21]

Monitoring & Evaluation

The Programme establishes a monitoring and evaluation system based on health-statistical data, specified programme indicators, direct inspections, patient databases, disease registers and routine reporting. The Institute of Public Health of Serbia coordinates this system and consolidates reports for the Ministry of Health.[21]

• Monitor preventive measures for people at high risk of hypertension and assess the effectiveness of preventive procedures during the first programme year.[3][18]
• Track adult systematic examinations in primary healthcare, identify people at high cardiovascular risk and assess the number of people with hypertension.[18]
• Measure progress against explicit hypertension targets: reduce the number of people with arterial hypertension by 5%, increase newly detected cases by 10% through improved diagnosis, and reduce complications by 10%.[3]
• Monitor healthy-lifestyle promotion, population health, child growth and development, nutritional status and dietary habits, using standardised dietary-quality assessment methods and national research studies.[5][22]
• Maintain population cardiovascular disease registers, including a register of severe genetically determined hyperlipoproteinaemias by 2015, to support treatment planning and monitoring among blood relatives.[9][5]
• Establish databases for congenital heart defects, cardiac surgery patients and rehabilitation recipients, and improve the national acute coronary syndrome registry.[10][11][14][15]
• Use prospective interventional-cardiology databases linked to the Republic Health Insurance Fund to monitor appropriate use of consumable medical materials.[11][12]
• Maintain a unified electronic database for pacemaker services at the Pacemaker Reference Centre of the Clinical Centre of Serbia, and gather annual questionnaire data from cardiology and emergency medical services to estimate arrhythmia prevalence and examine causes of sudden death.[12][23]
• Create prospective registers across prevention centres from primary to tertiary care to monitor population risk factors and the performance of healthcare institutions and public health institutes, while supporting intervention studies and clinical research.[16]
• Require health centres, primary-care institutions, cardiovascular clinics and hospital departments, and territorial public health institutes to submit implementation reports every six months to the Institute of Public Health of Serbia.[21]
• Conduct direct reviews of local government units, administrative districts and relevant Republic Health Insurance Fund branches, coordinated by competent public health institutions.[21]

Implementation accountability is chiefly through assigned doctors, with one coordinating doctor in each health centre, and through six-monthly reporting and inspection arrangements.[18][4][21]The available text does not set out a consolidated results framework, comprehensive quantitative indicator set, formal independent evaluation method or programme-wide evaluation timetable.[10][11][12][14][15][16]

Costing & Financing

Implementation is to be financed from the Republic of Serbia budget under the Ministry of Health, subject to budgetary capacity, and from resources planned in the financial plan of the Republic Health Insurance Fund.[21]No numeric programme budget, unit costs, funding-gap estimate or economic assumptions are specified.[21]

• Provide financing-related programme inputs through the wider framework covering financing, human resources, infrastructure and consumable supplies, although allocations and funding mechanisms are not detailed.[2]
• Plan resources for treatment of severe genetically determined hyperlipoproteinaemias and ensure access to appropriate therapy, without a stated monetary allocation.[5]
• Resource beds, personnel, equipment, medicines, catheterisation laboratories, service expansion, workforce training and pacemaker implantation and maintenance, without identifying budgets or financing sources for these requirements.[11][12]
• Define vascular-surgery procedures with associated staffing, consumable surgical, anaesthetic and transfusion materials, medicines and operating-room time, but without unit-cost estimates.[20]
• Address cardiac-surgery capacity needs, with approximately 9,000 interventions required annually, 4,500 currently performed and a further estimated 4,500 patients waiting; no financial valuation accompanies these figures.[13]
• Apply a five-year amortisation period to existing and newly opened catheterisation laboratories, followed by servicing in accordance with established protocols.[12]
• Support participation by Serbian institutions and researchers in cardiovascular stem-cell studies financed through international funds and the pharmaceutical industry; the text does not quantify this external financing.[21]

The Programme therefore identifies substantial capacity and resource needs, but does not provide costed activities, quantified resource mobilisation targets, allocations by implementing institution, affordability analysis or a defined financing-gap calculation.[11][12][20][13][14][15][16][21]